Company Revenue

The company’s orthopedic business declined in mid-single digits for 1Q20, with a precipitous -80% decline in April. However, Integra expects...

The company’s sales declined in the mid-single digits in 1Q20, but included a few bright spots like continuing adoption of...

The company’s late-2019 growth momentum continued for most of 1Q20, resulting in nearly 22.6% growth. ATEC is confident the spine...

The company was on pace to deliver double-digit growth in 1Q20 before COVID-related surgical delays, and procedures were down roughly...

The company’s 1Q20 growth amid COVID-19 was fueled by $6.8 million in sales from Parcus and Arthosurface, in addition to...

The company rode early 1Q momentum to grow in the low double-digits despite COVID-related procedure deferrals, and has seen signs...

The company managed to drive single-digit growth despite the late-March impact of COVID and expects to be well-positioned to benefit...

Orthopedic sales for the company declined 9.5% in 1Q20 before dropping by nearly half through April. However, the company sees...

NuVasive suffered modest impact from COVID-19 in 1Q20 and expects severe reductions in 2Q. However, the company is using its...

Vericel’s MACI revenue grew 22% in 1Q20 despite mid-March disruptions from COVID-19. The company believes it has passed the market...